• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经腋动脉置入Impella支持下的高危经皮冠状动脉介入治疗:一例报告

Navigating high-risk PCI with axillary impella support: a case report.

作者信息

Mahmoud Ahmed, Gupta Pukar, Regmi Nishchal, Adhikari Pradeep, Pandit Rohit, Thapa Roshni, Kaki Amir

机构信息

University of Giza, Giza, Egypt.

National Health Action Force Nepal, Kathmandu, Nepal.

出版信息

Ann Med Surg (Lond). 2025 Jul 18;87(8):5273-5276. doi: 10.1097/MS9.0000000000003550. eCollection 2025 Aug.

DOI:10.1097/MS9.0000000000003550
PMID:40787550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12333735/
Abstract

INTRODUCTION AND IMPORTANCE

Percutaneous coronary intervention (PCI) in high risk patients with complex coronary artery disease and impaired left ventricular function pose significant procedural challenges. During such interventions. Mechanical circulatory support with the Impella device has become an effective strategy to maintain hemodynamic stability. While femoral access is traditionally used, alternative routes like axillary artery access may be necessary in patients with peripheral vascular disease.

CASE PRESENTATION

We present the case of a 68-year-old male with severe multivessel coronary artery disease with reduced left ventricular ejection fraction, and bilateral iliofemoral artery disease. Since there was difficulty in accessing the femoral arteries, axillary artery access was used to insert an Impella CP device to support high-risk PCI. The procedure involved successful revascularization of complex lesions using rotational atherectomy and stenting. The patient remained hemodynamically stable throughout and recovered without complications.

DISCUSSION

In patients with contraindications to femoral access this case highlights the feasibility and clinical utility of axillary access for Impella insertion despite requiring surgical expertise and meticulous planning, the axillary route offers a safe and effective alternative for mechanical circulatory support during complex coronary interventions.

CONCLUSION

Axillary artery access for Impella-assisted high-risk PCI is a viable and underutilized option in select patients with complex coronary anatomy and peripheral vascular disease, expanding the therapeutic possibilities in advanced interventional cardiology. This report highlights a safe, effective alternative for patients with contraindications to femoral access and emphasizes the importance of multidisciplinary planning.

摘要

引言与重要性

对于患有复杂冠状动脉疾病且左心室功能受损的高危患者,经皮冠状动脉介入治疗(PCI)面临重大的手术挑战。在此类介入治疗期间,使用Impella装置进行机械循环支持已成为维持血流动力学稳定的有效策略。虽然传统上采用股动脉入路,但对于患有外周血管疾病的患者,可能需要像腋动脉入路这样的替代途径。

病例介绍

我们报告一例68岁男性患者,患有严重的多支冠状动脉疾病,左心室射血分数降低,且双侧髂股动脉疾病。由于股动脉穿刺困难,采用腋动脉入路插入Impella CP装置以支持高危PCI。该手术包括使用旋磨术和支架置入术成功实现复杂病变的血管再通。患者在整个手术过程中血流动力学保持稳定,且康复过程中无并发症。

讨论

对于有股动脉入路禁忌证的患者,本病例突出了腋动脉入路插入Impella装置的可行性和临床实用性。尽管需要手术专业知识和精心规划,但腋动脉途径为复杂冠状动脉介入治疗期间的机械循环支持提供了一种安全有效的替代方法。

结论

对于具有复杂冠状动脉解剖结构和外周血管疾病的特定患者,腋动脉入路用于Impella辅助的高危PCI是一种可行但未充分利用的选择,扩展了高级介入心脏病学的治疗可能性。本报告突出了对有股动脉入路禁忌证患者的一种安全有效的替代方法,并强调了多学科规划的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/08d435f6698b/ms9-87-5273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/f6de92b18ca0/ms9-87-5273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/4cf7a4bd1f64/ms9-87-5273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/08d435f6698b/ms9-87-5273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/f6de92b18ca0/ms9-87-5273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/4cf7a4bd1f64/ms9-87-5273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db2/12333735/08d435f6698b/ms9-87-5273-g003.jpg

相似文献

1
Navigating high-risk PCI with axillary impella support: a case report.经腋动脉置入Impella支持下的高危经皮冠状动脉介入治疗:一例报告
Ann Med Surg (Lond). 2025 Jul 18;87(8):5273-5276. doi: 10.1097/MS9.0000000000003550. eCollection 2025 Aug.
2
Short- and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction - Polish Impella Registry.多支冠状动脉疾病和低射血分数患者接受Impella保护的高危择期经皮冠状动脉介入治疗的短期和长期结果——波兰Impella注册研究
Cardiol J. 2025;32(3):248-257. doi: 10.5603/cj.103336. Epub 2025 Apr 14.
3
Cardiac Surgery心脏外科手术
4
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较:一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
5
Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlled.经调整的观察性研究和随机对照试验的直接和网络荟萃分析:严重射血分数降低患者经皮血运重建术、辅助支持治疗和非辅助支持治疗的中期死亡率比较。
Int J Cardiol. 2024 Feb 1;396:131428. doi: 10.1016/j.ijcard.2023.131428. Epub 2023 Oct 9.
6
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery.左心室射血分数降低且被认为不适合外科血运重建的患者的高风险经皮冠状动脉介入治疗。欧洲经皮心血管介入协会(EAPCI)与欧洲心脏病学会心血管外科工作组合作发布的临床共识声明。
EuroIntervention. 2025 Jan 6;21(1):22-34. doi: 10.4244/EIJ-D-23-01100.
7
Ultrasound-guided versus anatomic landmark-guided percutaneous femoral artery access.超声引导与解剖标志引导下经皮股动脉穿刺入路
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD014594. doi: 10.1002/14651858.CD014594.pub2.
8
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮与外科切开股动脉入路在择期分叉腹主动脉血管内修复术中的比较。
Cochrane Database Syst Rev. 2023 Jan 11;1(1):CD010185. doi: 10.1002/14651858.CD010185.pub4.
9
Percutaneous transluminal rotational atherectomy for coronary artery disease.经皮腔内冠状动脉旋磨术治疗冠状动脉疾病。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003334. doi: 10.1002/14651858.CD003334.pub2.
10
Outcomes of Percutaneous Access to the First Versus Third Segment of Axillary Artery During Aortic Procedures.主动脉手术中经皮穿刺腋动脉第一段与第三段的结果
J Endovasc Ther. 2023 Sep 26:15266028231202456. doi: 10.1177/15266028231202456.

本文引用的文献

1
Impact of frailty on outcomes following coronary artery bypass grafting: a systematic review and meta-analysis.衰弱对冠状动脉旁路移植术后结局的影响:一项系统评价和荟萃分析。
BMC Surg. 2024 Dec 27;24(1):419. doi: 10.1186/s12893-024-02728-1.
2
PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes.心力衰竭患者的经皮冠状动脉介入治疗:当前证据、完全血运重建的影响及改善预后的当代技术
J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100020. doi: 10.1016/j.jscai.2022.100020. eCollection 2022 Mar-Apr.
3
Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
Impella 循环支持治疗高危经皮冠状动脉介入治疗的短期结果:系统评价和荟萃分析。
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):27-36. doi: 10.1002/ccd.29757. Epub 2021 May 24.
4
Percutaneous Axillary Access for Placement of Microaxial Ventricular Support Devices: The Axillary Access Registry to Monitor Safety (ARMS).经皮腋窝入路植入微轴心室支持装置:监测安全性的腋窝入路注册研究(ARMS)。
Circ Cardiovasc Interv. 2021 Jan;14(1):e009657. doi: 10.1161/CIRCINTERVENTIONS.120.009657. Epub 2020 Dec 16.
5
The Impella Device: Historical Background, Clinical Applications and Future Directions.Impella装置:历史背景、临床应用及未来方向。
Int J Angiol. 2019 Jun;28(2):118-123. doi: 10.1055/s-0038-1676369. Epub 2018 Dec 20.
6
Insertion of the Impella via the axillary artery for high-risk percutaneous coronary intervention.经腋动脉置入Impella用于高危经皮冠状动脉介入治疗。
Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):540-544. doi: 10.1016/j.carrev.2017.12.016. Epub 2018 Jan 5.
7
The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.用于高危经皮冠状动脉介入治疗的Impella心室辅助装置的有效性和安全性:一项系统评价。
Catheter Cardiovasc Interv. 2018 Jun;91(7):1250-1260. doi: 10.1002/ccd.27316. Epub 2017 Sep 20.
8
Percutaneous left axillary artery approach for Impella 2.5 liter circulatory support for patients with severe aortoiliac arterial disease undergoing high-risk percutaneous coronary intervention.经皮左腋动脉入路在高危经皮冠状动脉介入治疗中为严重主髂动脉疾病患者提供 Impella 2.5 升循环支持。
J Interv Cardiol. 2012 Apr;25(2):210-3. doi: 10.1111/j.1540-8183.2011.00696.x. Epub 2012 Feb 20.